The Estrogen Receptor (ER) market is a segment of the Endocrine and Metabolic Disorders Drugs market. ER drugs are used to treat a variety of conditions, including menopausal symptoms, osteoporosis, and breast cancer. ER drugs work by binding to the estrogen receptor, which is found in many tissues throughout the body. This binding triggers a cascade of events that can lead to the desired therapeutic effect. ER drugs are typically administered orally, as a topical cream, or as an injection. ER drugs are typically prescribed to postmenopausal women, as well as to men with certain conditions. The market for ER drugs is expected to grow in the coming years, driven by an aging population and increasing awareness of the importance of hormone therapy. Some companies in the ER market include Pfizer, Novartis, Merck, and AstraZeneca. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
